Clinical Trial Update: Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the safety and immunogenicity of an inactivated H5N1 influenza vaccine (whole virion, vero cell-derived) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H5n1 Influenza

Drugs mentioned

• Inactivated H5N1 influenza vaccine (whole virion, Vero cell derived) (inactivated H5N1 influenza vaccine)

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Influenza | Phase 1, Phase 2 | Status: COMPLETED